Found: 29
Select item for more details and to access through your institution.
The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma.
- Published in:
- Brain Communications, 2024, v. 6, n. 4, p. 1, doi. 10.1093/braincomms/fcae241
- By:
- Publication type:
- Article
Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 162, n. 1, p. 225, doi. 10.1007/s11060-023-04285-8
- By:
- Publication type:
- Article
The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 154, n. 1, p. 73, doi. 10.1007/s11060-021-03800-z
- By:
- Publication type:
- Article
Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 142, n. 3, p. 463, doi. 10.1007/s11060-019-03117-y
- By:
- Publication type:
- Article
A multidisciplinary neuro-oncological triage panel reduces the time to referral and treatment for patients with a brain tumor.
- Published in:
- Neuro-Oncology Practice, 2021, v. 8, n. 5, p. 559, doi. 10.1093/nop/npab040
- By:
- Publication type:
- Article
Recruiting Adolescent and Young Adult Cancer Survivors for Patient-Reported Outcome Research: Experiences and Sample Characteristics of the SURVAYA Study.
- Published in:
- Current Oncology, 2022, v. 29, n. 8, p. 5407, doi. 10.3390/curroncol29080428
- By:
- Publication type:
- Article
Health-related quality of life of Adolescent and Young Adult Cancer Survivors before and during the COVID-19 pandemic: longitudinal improvements on social functioning and fatigue.
- Published in:
- Journal of Patient-Reported Outcomes, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41687-023-00629-0
- By:
- Publication type:
- Article
Health-related quality of life of Adolescent and Young Adult Cancer Survivors before and during the COVID-19 pandemic: longitudinal improvements on social functioning and fatigue.
- Published in:
- Journal of Patient-Reported Outcomes, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41687-023-00629-0
- By:
- Publication type:
- Article
Patient-Reported Outcomes of Accelerated Aging: A Novel Approach to Investigate Second Cancer Risk in Adolescent and Young Adult (18−39 Years) Cancer Survivors.
- Published in:
- Oncologist, 2024, v. 29, n. 4, p. e526, doi. 10.1093/oncolo/oyad307
- By:
- Publication type:
- Article
Reducing severe fatigue in patients with diffuse glioma: a study protocol for an RCT on the effect of blended cognitive behavioural therapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad149
- By:
- Publication type:
- Article
Learning from long‐term adolescent and young adult (AYA) cancer survivors regarding their age‐specific care needs to improve current AYA care programs.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 12, p. 13712, doi. 10.1002/cam4.6001
- By:
- Publication type:
- Article
Non-invasively measured brain activity and radiological progression in diffuse glioma.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-97818-y
- By:
- Publication type:
- Article
Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?
- Published in:
- 2023
- By:
- Publication type:
- Editorial
A Negative Body Image among Adolescent and Young Adult (AYA) Cancer Survivors: Results from the Population-Based SURVAYA Study.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5243, doi. 10.3390/cancers14215243
- By:
- Publication type:
- Article
First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
- Published in:
- Epilepsia (Series 4), 2021, v. 62, n. 5, p. 1119, doi. 10.1111/epi.16880
- By:
- Publication type:
- Article
Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: A longitudinal study spanning two decades.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 2, p. 351, doi. 10.1093/neuonc/noac185
- By:
- Publication type:
- Article
Patients with primary brain tumors and COVID-19: A report from the Dutch Oncology COVID-19 Consortium.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 326, doi. 10.1093/neuonc/noab258
- By:
- Publication type:
- Article
P14.51 Can patients with a suspected high-grade glioma receive tumor treatment during pregnancy safely?
- Published in:
- 2021
- By:
- Publication type:
- Abstract
P14.13 Severe hematological toxicity during chemoradiation for glioblastoma: Identification of clinical and pharmacological risk factors and consequences for the individual patient.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii40, doi. 10.1093/neuonc/noab180.138
- By:
- Publication type:
- Article
P12.07 The potential of cannabinoids to improve quality of life in glioma patients: A meta-analysis in patients with neurological and oncological disease.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
P12.02 Symptoms of patients with diffuse glioma during stable disease as a potential target for treatment.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii30, doi. 10.1093/neuonc/noab180.104
- By:
- Publication type:
- Article
P12.01 The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii30, doi. 10.1093/neuonc/noab180.103
- By:
- Publication type:
- Article
P11.01 Symptom networks in glioma: a novel approach to study multidimensional symptomatology in glioma patients.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii28, doi. 10.1093/neuonc/noab180.097
- By:
- Publication type:
- Article
OS10.8.A The effectiveness of antiepileptic drug duotherapies in glioma patients: a multicenter observational cohort study.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii14, doi. 10.1093/neuonc/noab180.046
- By:
- Publication type:
- Article
OS09.4.A Health-related quality of life in low-grade glioma survivors 26 years after diagnosis.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii12, doi. 10.1093/neuonc/noab180.038
- By:
- Publication type:
- Article
OS09.3.A Caregiver burden of glioma patients: the impact of informal care.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii12, doi. 10.1093/neuonc/noab180.037
- By:
- Publication type:
- Article
OS05.7.A Absence of severe hematological toxicity during first line treatment predicts low chance on severe toxicity during second line alkylating chemotherapy in glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii8, doi. 10.1093/neuonc/noab180.023
- By:
- Publication type:
- Article
OS05.5.A Methylation analysis of matched primary and recurrent IDHmt astrocytoma; an update from the Glioma Longitudinal Analysis NL (GLASS-NL) consortium.
- Published in:
- Neuro-Oncology, 2021, v. 23, p. ii7, doi. 10.1093/neuonc/noab180.022
- By:
- Publication type:
- Article